5th Apr 2016 08:12
LONDON (Alliance News) - Biomedical and healthcare technology firm NetScientific PLC on Tuesday said it has appointed Ian Postlethwaite as its chief financial officer.
NetScientific has poached Postlethwaite from Allergy Therapeutics PLC, the AIM-listed allergy treatments developer. Allergy had announced in March that Postlethwaite had resigned in order to pursue a new opportunity, on which it had not provided any further details at the time.
NetScientific said Postlethwaite will join once Allergy has found a replacement and allowed time for an orderly handover. Allergy had previously said Postlethwaite would remain in his current role for up to six months.
NetScientific shares were untraded on Tuesday, having last traded at 72.00 pence. Allergy Therapeutics shares were up 1.2% at 26.68p.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Allergy Thera.Netscientific